Clinical Trial of Gene Therapy for Leber Congenital Amaurosis Caused by RPE65 Mutations

Clinical trial NCT00821340 · COMPLETED

Trial details

NCT number: NCT00821340
Sponsor: Hadassah Medical Organization
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Leber Congenital Amaurosis

Start date: 2009-02-01
Primary completion: 2016-06-29
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.